Why some patients quit a newer insomnia medication
Researchers from Rutgers and other universities analyzed hundreds of online reviews on lemborexant—and learned that about 1 in 4 of the reviewers stopped or planned to stop taking the prescription medication used to treat insomnia.
Read original article on Medical Xpress - latest medical and health news stories →Related news
-
Space-grown glioblastoma organoids could help advance brain cancer treatments
United Kingdom
-
Not all antihistamines are the same—and some may affect your brain more than you think
United Kingdom
-
Human skin models reveal how herpes spreads unevenly among neighboring cells
United Kingdom
-
Team publishes largest-ever dataset on real-world psychedelic support interactions
United Kingdom
-
Can creatine help your mental health? Here's what the latest evidence says
United Kingdom
-
Post-COVID syndrome: Prednisolone shows modest, short-lived lift in treatment trial
United Kingdom
-
First patient undergoes pioneering stem-cell treatment for Parkinson's
United Kingdom
-
Checkpoint immunotherapy reshapes immune environment in lymph nodes after melanoma reaches them
United Kingdom